The emergence of oxidized low-density lipoprotein (OxLDL) is crucial for the progression of cardiovascular diseases (CVD) linked to atherosclerosis. OxLDL stimulates endothelial activation and smooth muscle proliferation and has an atheroscleroticpromoting effect. The measurement of OxLDL correlates with the presence of CVD and may be a prognostic marker for future health outcomes. Circulating OxLDLs can be used as biomarkers since their levels rise in patients with advanced atherosclerosis. Immunological methods have proven to be very useful methodologies. Anti-OxLDL monoclonal antibodies have been developed that bind strongly to OxLDL and are used in ELISA for OxLDL measurements. Routine inclusion of OxLDL estimation in an at-risk population can help the clinicians understand the disease initiation and progression and improve early intervention and management.
机构:
Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, ScotlandAston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
Greig, Fiona H.
;
Kennedy, Simon
论文数: 0引用数: 0
h-index: 0
机构:
Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, ScotlandAston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
机构:
Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, ScotlandAston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
Greig, Fiona H.
;
Kennedy, Simon
论文数: 0引用数: 0
h-index: 0
机构:
Univ Glasgow, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow G12 8QQ, Lanark, ScotlandAston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England